Connect with us

Hi, what are you looking for?

Alive Business PlanAlive Business Plan

Stock

GSK CEO plans more deals, focuses on cancer medicines

Investing.com — GSK Plc’s CEO Emma Walmsley has expressed intentions to engage in more business deals, as the British pharmaceutical company intensifies its focus on cancer treatments. This comes after GSK made several agreements in 2024, including a deal with cancer biotech firm IDRx, Inc., worth up to $1.15 billion, which was announced on Monday.

The acquisition of IDRx is aimed at procuring an experimental drug for the treatment of gastrointestinal stromal tumors. If the drug proves successful, it will be the first significant advancement in nearly two decades, according to the companies.

Walmsley stated that GSK’s renewed focus on oncology is a strategic move to expand its specialty medicines portfolio. The company has plans to advance the IDRx drug to late-stage trials within the year.

In response to questions concerning the vaccine skepticism of Robert F. Kennedy Jr., President-elect Donald Trump’s nominee for the Department of Health and Human Services, Walmsley stated that GSK had a fruitful collaboration with the first Trump administration. Looking ahead to 2025, she expressed optimism and ambition.

Walmsley also addressed concerns about potential tariff threats from Trump’s administration. She pointed out that historically, tariffs have not been applied to healthcare. She emphasized GSK’s commitment to its operations in America, but also noted the company’s global presence and its priority to deliver its products to those in need.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

This post appeared first on investing.com
Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!

    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    You May Also Like

    Latest News

    The Gateway Pundit, a far-right website, published a note from its editor on Saturday acknowledging that two election workers in Georgia did not engage...

    Latest News

    Sister Stephanie Schmidt had a hunch about what her fellow nuns would discuss over dinner at their Erie, Pennsylvania, monastery on Wednesday night. The...

    Investing

    JAKARTA (Reuters) -Indonesia has asked Alphabet (NASDAQ:GOOGL)’s Google and Apple (NASDAQ:AAPL) to block Chinese fast fashion e-commerce firm Temu in their application stores in...

    Latest News

    New majorities in Congress, particularly when the incoming party has a new leader, offer the rare chance for the institution to take a breath...



    Disclaimer: alivebusinessplan.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2024 alivebusinessplan.com